AAAAAA
Results: 376-400/1162
Authors:
Choo, CK
Ling, MT
Chan, KW
Tsao, SW
Zheng, Z
Zhang, DK
Chan, LC
Wong, YC
Citation: Ck. Choo et al., Immortalization of human prostate epithelial cells by HPV 16 E6/E7 open reading frames, PROSTATE, 40(3), 1999, pp. 150-158
Authors:
Sundareshan, P
Nagle, RB
Bowden, GT
Citation: P. Sundareshan et al., EGF induces the expression of matrilysin in the human prostate adenocarcinoma cell line, LNCaP, PROSTATE, 40(3), 1999, pp. 159-166
Authors:
Sakamoto, N
Hasegawa, Y
Koga, H
Kotoh, S
Kuroiwa, K
Naito, S
Citation: N. Sakamoto et al., Presence of ganglia within the prostatic capsule: Ganglion involvement in prostatic cancer, PROSTATE, 40(3), 1999, pp. 167-171
Authors:
Nastiuk, KL
Mansukhani, M
Terry, MB
Kularatne, P
Rubin, MA
Melamed, J
Gammon, MD
Ittmann, M
Krolewski, JJ
Citation: Kl. Nastiuk et al., Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men, PROSTATE, 40(3), 1999, pp. 172-177
Authors:
Davol, PA
Frackelton, AR
Citation: Pa. Davol et Ar. Frackelton, Targeting human prostatic carcinoma through basic fibroblast growth factorreceptors in an animal model: Characterizing and circumventing mechanisms of tumor resistance, PROSTATE, 40(3), 1999, pp. 178-191
Authors:
Liu, AY
True, LD
LaTray, L
Ellis, WJ
Vessella, RL
Lange, PH
Higano, CS
Hood, L
van den Engh, G
Citation: Ay. Liu et al., Analysis and sorting of prostate cancer cell types by flow cytometry, PROSTATE, 40(3), 1999, pp. 192-199
Authors:
Liang, JY
Liu, YY
Zou, J
Franklin, RB
Costello, LC
Feng, P
Citation: Jy. Liang et al., Inhibitory effect of zinc on human prostatic carcinoma cell growth, PROSTATE, 40(3), 1999, pp. 200-207
Authors:
Angelsen, A
Falkmer, S
Sandvik, AK
Waldum, HL
Citation: A. Angelsen et al., Pre- and postnatal testosterone administration induces proliferative epithelial lesions with neuroendocrine differentiation in the dorsal lobe of therat prostate, PROSTATE, 40(2), 1999, pp. 65-75
Authors:
Henriksson, P
Carlstrom, K
Pousette, A
Gunnarsson, PO
Johansson, CJ
Eriksson, B
Altersgard-Brorsson, AK
Nordle, O
Stege, R
Citation: P. Henriksson et al., Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteralestrogen regimen, PROSTATE, 40(2), 1999, pp. 76-82
Authors:
Saez, C
Gonzalez-Baena, AC
Japon, MA
Giraldez, J
Segura, DI
Rodriguez-Vallejo, JM
Gonzalez-Esteban, J
Miranda, G
Torrubia, F
Citation: C. Saez et al., Expression of basic fibroblast growth factor and its receptors FGFRI and FGFR2 in human benign prostatic hyperplasia treated with finasteride, PROSTATE, 40(2), 1999, pp. 83-88
Authors:
de la Taille, A
Chen, MW
Shabsigh, A
Bagiella, E
Kiss, A
Buttyan, R
Citation: A. De La Taille et al., Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland, PROSTATE, 40(2), 1999, pp. 89-96
Authors:
Beemsterboer, PMM
de Koning, HJ
Birnie, E
van der Maas, PJ
Schroder, FH
Citation: Pmm. Beemsterboer et al., Advanced prostate cancer: Course, care, and cost implications, PROSTATE, 40(2), 1999, pp. 97-104
Authors:
Kirby, R
Robertson, C
Turkes, A
Griffiths, K
Denis, L
Boyle, P
Altwein, J
Schroder, F
Citation: R. Kirby et al., Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage M1 carcinoma of the prostate gland, PROSTATE, 40(2), 1999, pp. 105-114
Authors:
Chang, WY
Prins, GS
Citation: Wy. Chang et Gs. Prins, Estrogen receptor-beta: Implications for the prostate gland, PROSTATE, 40(2), 1999, pp. 115-124
Authors:
Tjoa, BA
Simmons, SJ
Elgamal, A
Rogers, M
Ragde, H
Kenny, GM
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Ba. Tjoa et al., Follow-up evaluation of a phase II prostate cancer vaccine trial, PROSTATE, 40(2), 1999, pp. 125-129
Authors:
Boer, R
Schroder, FH
Citation: R. Boer et Fh. Schroder, Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reduction, PROSTATE, 40(2), 1999, pp. 130-131
Authors:
Labrie, F
Candas, B
Citation: F. Labrie et B. Candas, Various statistical analyses indicate a marked reduction of prostate cancer death in the Quebec trial, PROSTATE, 40(2), 1999, pp. 132-134
Authors:
Alexander, FE
Prescott, RJ
Citation: Fe. Alexander et Rj. Prescott, Various statistical analyses indicate a marked reduction of prostate cancer death in the Quebec trial - Reply, PROSTATE, 40(2), 1999, pp. 135-136
Authors:
Labrie, F
Candas, B
Citation: F. Labrie et B. Candas, The Quebec study shows a 69% decrease in prostate cancer death, PROSTATE, 40(2), 1999, pp. 137-137
Authors:
Russell, PJ
Bennett, S
Joshua, A
Yu, Y
Dowing, SR
Hill, MA
Kingsley, EA
Mason, RS
Berry, J
Citation: Pj. Russell et al., Elevated expression of FGF-2 does not cause prostate cancer progression inLNCaP cells, PROSTATE, 40(1), 1999, pp. 1-13
Authors:
Lee, HK
Driscoll, D
Asch, H
Asch, B
Zhang, PJ
Citation: Hk. Lee et al., Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate, PROSTATE, 40(1), 1999, pp. 14-19
Authors:
Rohrbach, H
Haas, CJ
Baretton, GB
Hirschmann, A
Diebold, J
Behrendt, RP
Lohrs, U
Citation: H. Rohrbach et al., Microsatellite instability and loss of heterozygosity in prostatic carcinomas: Comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases, PROSTATE, 40(1), 1999, pp. 20-27
Authors:
d'Ancona, FCH
Albers, YHM
Kiemeney, LA
Xue, Y
Smedts, F
van der Poel, HG
Debruyne, FMJ
de la Rosette, JJMCH
Citation: Fch. D'Ancona et al., Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study, PROSTATE, 40(1), 1999, pp. 28-36
Authors:
Yuan, RQ
Fan, JA
Meng, QH
Ma, YX
Schreiber, D
Goldberg, ID
Rosen, EM
Citation: Rq. Yuan et al., Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells, PROSTATE, 40(1), 1999, pp. 37-49
Authors:
Wang, JD
Takahara, S
Nonomura, N
Ichimaru, N
Toki, K
Azuma, H
Matsumiya, K
Okuyama, A
Suzuki, S
Citation: Jd. Wang et al., Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation, PROSTATE, 40(1), 1999, pp. 50-55